What top creators are saying about Acadia Pharmaceuticals Inc.(ACAD)

Biopharmaceutical company

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Acadia Pharmaceuticals Inc..

Strongly bullish
avg +0.70
1 bullish0 neutral0 bearish

Top creators covering Acadia Pharmaceuticals Inc. (ACAD)

The 1 sources with the most insights about Acadia Pharmaceuticals Inc. on Kazuha.

Latest insights about Acadia Pharmaceuticals Inc. (ACAD)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Very Bullish
Target: $5 billion revenue

Considering a long position; believes Essential Tremor drug is undervalued despite patent cliff risks.

Martin Shkreli
7/7/26 -2.9%
Martin ShkreliYouTube3 hours ago

Discussed alongside Acadia Pharmaceuticals Inc. (ACAD)

Other assets that creators frequently mention in the same content as Acadia Pharmaceuticals Inc..

Frequently asked

Which podcasters and creators cover Acadia Pharmaceuticals Inc. (ACAD) the most?

The most active sources covering Acadia Pharmaceuticals Inc. (ACAD) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Acadia Pharmaceuticals Inc. (ACAD) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Acadia Pharmaceuticals Inc. (ACAD) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Acadia Pharmaceuticals Inc. (ACAD)?

Creators covering Acadia Pharmaceuticals Inc. (ACAD) most frequently also discuss BTC, KRNT, CORW, INTC, BBAI. See the "Discussed alongside" section above for full asset pages.